Epidemiology of intra-abdominal infection and sepsis in critically ill patients: "AbSeS", a multinational observational cohort study and ESICM Trials Group Project.
[en] PURPOSE: To describe the epidemiology of intra-abdominal infection in an international cohort of ICU patients according to a new system that classifies cases according to setting of infection acquisition (community-acquired, early onset hospital-acquired, and late-onset hospital-acquired), anatomical disruption (absent or present with localized or diffuse peritonitis), and severity of disease expression (infection, sepsis, and septic shock). METHODS: We performed a multicenter (n = 309), observational, epidemiological study including adult ICU patients diagnosed with intra-abdominal infection. Risk factors for mortality were assessed by logistic regression analysis. RESULTS: The cohort included 2621 patients. Setting of infection acquisition was community-acquired in 31.6%, early onset hospital-acquired in 25%, and late-onset hospital-acquired in 43.4% of patients. Overall prevalence of antimicrobial resistance was 26.3% and difficult-to-treat resistant Gram-negative bacteria 4.3%, with great variation according to geographic region. No difference in prevalence of antimicrobial resistance was observed according to setting of infection acquisition. Overall mortality was 29.1%. Independent risk factors for mortality included late-onset hospital-acquired infection, diffuse peritonitis, sepsis, septic shock, older age, malnutrition, liver failure, congestive heart failure, antimicrobial resistance (either methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, extended-spectrum beta-lactamase-producing Gram-negative bacteria, or carbapenem-resistant Gram-negative bacteria) and source control failure evidenced by either the need for surgical revision or persistent inflammation. CONCLUSION: This multinational, heterogeneous cohort of ICU patients with intra-abdominal infection revealed that setting of infection acquisition, anatomical disruption, and severity of disease expression are disease-specific phenotypic characteristics associated with outcome, irrespective of the type of infection. Antimicrobial resistance is equally common in community-acquired as in hospital-acquired infection.
Disciplines :
Anesthesia & intensive care
Author, co-author :
Blot, Stijn
Antonelli, Massimo
Arvaniti, Kostoula
Blot, Koen
Creagh-Brown, Ben
de Lange, Dylan
De Waele, Jan
Deschepper, Mieke
Dikmen, Yalim
Dimopoulos, George
Eckmann, Christian
Francois, Guy
Girardis, Massimo
Koulenti, Despoina
Labeau, Sonia
Lipman, Jeffrey
Lipovestky, Fernando
Maseda, Emilio
Montravers, Philippe
Mikstacki, Adam
Paiva, Jose-Artur
Pereyra, Cecilia
Rello, Jordi
Timsit, Jean-Francois
Vogelaers, Dirk
Abdominal Sepsis Study (AbSeS) group on behalf of the Trials Group of the European Society of Intensive Care Medicine
Misset, Benoît ; Centre Hospitalier Universitaire de Liège - CHU > Autres Services Médicaux > Service des soins intensifs
Language :
English
Title :
Epidemiology of intra-abdominal infection and sepsis in critically ill patients: "AbSeS", a multinational observational cohort study and ESICM Trials Group Project.
Vincent JL, Rello J, Marshall J et al (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA 302:2323–2329. 10.1001/jama.2009.1754
Kübler A, Adamik B, Ciszewicz-Adamiczka B, Ostrowska E (2015) Severe sepsis in intensive care units in Poland—a point prevalence study in 2012 and 2013. Anaesthesiol Intensive Ther 47:315–319. 10.5603/AIT.2015.0047
Sakr Y, Jaschinski U, Wittebole X et al (2018) Sepsis in intensive care unit patients: worldwide data from the intensive care over nations audit. Open Forum Infect Dis 5:ofy313. 10.1093/ofid/ofy313
Blot S, De Waele JJ (2005) Critical issues in the clinical management of complicated intra-abdominal infections. Drugs 65:1611–1620
Montravers P, Blot S, Dimopoulos G et al (2016) Therapeutic management of peritonitis: a comprehensive guide for intensivists. Intensive Care Med 42:1234–1247. 10.1007/s00134-016-4307-6
Solomkin JS, Mazuski JE, Bradley JS et al (2010) Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect (Larchmt) 11:79–109. 10.1089/sur.2009.9930
Azuhata T, Kinoshita K, Kawano D et al (2014) Time from admission to initiation of surgery for source control is a critical determinant of survival in patients with gastrointestinal perforation with associated septic shock. Crit Care 18:R87. 10.1186/cc13854
Sartelli M, Chichom-Mefire A, Labricciosa FM et al (2017) The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg 12:29. 10.1186/s13017-017-0141-6
Tolonen M, Coccolini F, Ansaloni L et al (2018) Getting the invite list right: a discussion of sepsis severity scoring systems in severe complicated intra-abdominal sepsis and randomized trial inclusion criteria. World J Emerg Surg 13:17. 10.1186/s13017-018-0177-2
Blot S, De Waele JJ, Vogelaers D (2012) Essentials for selecting antimicrobial therapy for intra-abdominal infections. Drugs 72:e17–e32. 10.2165/11599800-000000000-00000
Calandra T, Cohen J (2005) International Sepsis Forum Definition of Infection in the ICU Consensus Conference The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 33:1538–1548. 10.1097/01.ccm.0000168253.91200.83
Trouillet JL, Chastre J, Vuagnat A et al (1998) Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 157:531–539. 10.1164/ajrccm.157.2.9705064
Singer M, Deutschman CS, Seymour CW, et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):801–810. 10.1001/jama.2016.0287
The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0, 2015. http://www.eucast.org. Accessed 31 Mar 2014
Kadri SS, Adjemian J, Lai YL et al (2018) Difficult-to-treat resistance in gram-negative bacteremia at 173 US hospitals: retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all first-line agents. Clin Infect Dis 67:1803–1814. 10.1093/cid/ciy378
Kadri SS, Lai YLE, Ricotta EE et al (2019) External validation of difficult-to-treat resistance prevalence and mortality risk in gram-negative bloodstream infection using electronic health record data from 140 US hospitals. Open Forum Infect Dis 6:ofz110. 10.1093/ofid/ofz110
Versporten A, Zarb P, Caniaux I et al (2018) Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob Health 6:e619–e629. 10.1016/S2214-109X(18)30186-4
Vogelaers D, De Bels D, Forêt F et al (2010) Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates—a multicentre, observational survey in critically ill patients. Int J Antimicrob Agents 35:375–381. 10.1016/j.ijantimicag.2009.11.015
Solomkin JS, Yellin AE, Rotstein OD et al (2003) Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial. Ann Surg 237:235–245. 10.1097/01.SLA.0000048551.32606.73
Solomkin JS, Wilson SE, Christou NV et al (2001) Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections. Ann Surg 233:79–87. 10.1097/00000658-200101000-00013
Solomkin JS, Reinhart HH, Dellinger EP et al (1996) Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group. Ann Surg 223:303–315. 10.1097/00000658-199603000-00012
de Ruiter J, Weel J, Manusama E et al (2009) The epidemiology of intra-abdominal flora in critically ill patients with secondary and tertiary abdominal sepsis. Infection 37:522–527. 10.1007/s15010-009-8249-6
Blot K, Hammami N, Blot S et al (2019) Increasing burden of Escherichia coli, Klebsiella pneumoniae, and Enterococcus faecium in hospital-acquired bloodstream infections (2000–2014): a national dynamic cohort study. Infect Control Hosp Epidemiol 40:705–709. 10.1017/ice.2019.59
Martínez ML, Ferrer R, Torrents E et al (2017) Impact of source control in patients with severe sepsis and septic shock. Crit Care Med 45:11–19. 10.1097/CCM.0000000000002011
Montravers P, Dupont H, Gauzit R et al (2006) Candida as a risk factor for mortality in peritonitis. Crit Care Med 34:646–652. 10.1097/01.CCM.0000201889.39443.D2
Knitsch W, Vincent JL, Utzolino S et al (2015) A randomized, placebo-controlled trial of preemptive antifungal therapy for the prevention of invasive candidiasis following gastrointestinal surgery for intra-abdominal infections. Clin Infect Dis 61:1671–1678. 10.1093/cid/civ707
van de Groep K, Verhoeff TL, Verboom DM et al (2019) Epidemiology and outcomes of source control procedures in critically ill patients with intra-abdominal infection. J Crit Care 52:258–264. 10.1016/j.jcrc.2019.02.029
